Literature DB >> 21682613

Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implant.

Ilse Degreef1, Sabine Tejpar, Luc De Smet.   

Abstract

In this case-control prospective study, we investigated if we could improve the surgical outcome of interrupting strands in Dupuytren disease by creating a blocking effect with an absorbable cellulose implant, a known absorbable adhesion barrier. We studied 33 operations in 29 patients who had the potential for recurrent disease. The cellulose was implanted in the first 15 patients. An intraindividual control was added in 4 patients, who were given the implant in 1 of 2 operated hands. Goniometric evolution was monitored on digital photography, and satisfaction was measured on a visual analogue scale (VAS) with a preliminary one year follow-up. With the implant the postoperative range of movement improved significantly (by 33%) and remained unchanged after three months to a one year follow-up. The VAS for satisfaction also improved. We conclude that cellulose implants may improve the outcome of segmental fasciectomy in Dupuytren disease by achieving a better extension of fingers and a higher patients' satisfaction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682613     DOI: 10.3109/2000656X.2011.558725

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  3 in total

1.  Current concepts in Dupuytren's disease.

Authors:  Steven Lo; Mark Pickford
Journal:  Curr Rev Musculoskelet Med       Date:  2013-03

Review 2.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

Review 3.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.